India: ChrysCapital in talks to exit Eris Lifesciences via IPO

Private equity (PE) firm ChrysCapital is looking to exit its investment in pharmaceutical firm Eris Lifesciences through an initial public offering (IPO) and has initiated talks for the same, said three people aware of the development.
The move comes after ChrysCapital’s talks to exit through a secondary stake sale to other private equity firms.